The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits
暂无分享,去创建一个
[1] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.
[2] R. Wissler,et al. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas. , 1983, Applied pathology.
[3] J L Witztum,et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] A Daugherty,et al. Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits , 1989, British journal of pharmacology.
[5] J L Witztum,et al. Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Yokoyama,et al. Probucol prevents lipid storage in macrophages. , 1986, Atherosclerosis.
[7] M. Haberland,et al. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.
[8] T. Carew,et al. A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. , 1984, Journal of lipid research.
[9] B. Sobel,et al. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. , 1988, Arteriosclerosis.
[10] D. Satonin,et al. Comparison of gas chromatography and high-performance liquid chromatography for the analysis of probucol in plasma. , 1986, Journal of chromatography.
[11] T. Kita,et al. Cellular Pathology of Progressive Atherosclerosis in the WHHL Rabbit: An Animal Model of Familial Hypercholesterolemia , 1983, Arteriosclerosis.
[12] C. Glueck,et al. Quantitative analysis of cholesterol in 5 to 20 μl of plasma , 1974 .
[13] R. Havel,et al. Concentration and Composition of Lipoproteins in Blood Plasma of the WHHL Rabbit , 1982, Arteriosclerosis.
[14] L. McLean,et al. Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper. , 1989, Biochemistry.
[15] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[16] A. Ooshima,et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Edwards,et al. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[18] Y. Matsuzawa,et al. Effects of probucol on homozygous cases of familial hypercholesterolemia. , 1983, Atherosclerosis.
[19] M. Tomikawa,et al. Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit. , 1986, Japanese journal of pharmacology.
[20] A. Gown,et al. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.
[21] T. Carew,et al. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Shio,et al. Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. , 1979, Laboratory investigation; a journal of technical methods and pathology.
[23] S. Young,et al. Probucol inhibits oxidative modification of low density lipoprotein. , 1986, The Journal of clinical investigation.
[24] D. Steinberg,et al. Studies on the mechanism of action of probucol. , 1986, The American journal of cardiology.
[25] G. Cazzolato,et al. Presence of a Modified Low Density Lipoprotein in Humans , 1988, Arteriosclerosis.
[26] J. Wakasugi,et al. Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. , 1988, The American journal of cardiology.
[27] O. Stein,et al. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. , 1989, Atherosclerosis.
[28] A. Gown,et al. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.
[29] Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978 .
[30] R. N. Brogden,et al. Probucol , 1989, Drugs.
[31] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[32] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[33] S. Glagov,et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.
[34] D. Steinberg,et al. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Gown,et al. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. , 1989, The American journal of pathology.
[36] R. Jackson,et al. Probucol does not alter acetylated low density lipoprotein uptake by murine peritoneal macrophages. , 1990, Atherosclerosis.
[37] R. Jackson,et al. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. , 1989, Journal of lipid research.
[38] 佐藤 敬. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method , 1979 .
[39] S. Udenfriend,et al. A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.
[40] D. Kritchevsky,et al. Influence of 4,4'-(Isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on Experimental Atherosclerosis in Rabbits 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.